Council for Innovation Promotion

Over the weekend, former DNC Chair and Vermont Gov. Howard Dean published an opinion piece in the Boston Herald encouraging Congress to pass the Patent Eligibility Restoration Act. The legislation, introduced by Senators Chris Coons (D-DE) and Thom Tillis (R-NC), aims to eliminate uncertainty caused by Supreme Court rulings around what types of inventions are

On July 31, the National Institutes of Health (NIH) held a workshop with the intent of delving into the policies and methods that guide biomedical innovation and ensure public access to discoveries supported by the agency. The forum aimed to address the NIH’s approach to patenting and licensing biomedical inventions. Additional topics included the agency’s

Claim: The American Civil Liberties Union (ACLU) published a statement announcing that it would oppose the recently reintroduced Patent Eligibility Restoration Act (PERA) on the grounds that “If passed, the Act would allow corporations and other entities to patent laws of nature and products of nature, including naturally-occurring genes.” Correction: The Patent Eligibility Restoration Act explicitly does not allow

C4IP is recognizing Ralph Baer, who transformed the entertainment industry and is known as “The Father of Video Games.” Ralph Baer was born in 1922 to a Jewish family living in southwest Germany. In 1938, his family immigrated to the United States, where Baer developed a love for electronics and trained to become a radio service technician at

Last week, C4IP’s Board of Directors published an opinion piece in the Brussels Morning News on new regulations proposed by the European Commission, which would establish a “Competency Centre” at the European Union Intellectual Property Office (EUIPO) to govern the standard-essential patents (SEPs) that cover shared tech industry practices. In the piece, C4IP’s board argues

The month of July was a busy one for C4IP! Here’s a roundup of what our Coalition has been up to over the past month. On July 26, C4IP submitted comments to the NIH regarding the agency’s upcoming workshop, “Transforming Discoveries into Products: Maximizing NIH’s Levers to Catalyze Technology Transfer.” On July 26, C4IP Chief Policy Officer and Counsel